How Solving a Hepatitis B Paradox Opened the Door to New Therapies
February 22, 2025
February 22, 2025
NEW YORK, Feb. 22 -- Rockefeller University issued the following news:
* * *
How solving a hepatitis B paradox opened the door to new therapies
Hepatitis B virus (HBV) affects 300 million people worldwide and is a major driver of liver diseases. But while decades of research have led to vaccines, antivirals, and a better understanding of the virus, how this pathogen establishes persistent infection in cells at the molecular level remains poorly understood.< . . .
* * *
How solving a hepatitis B paradox opened the door to new therapies
Hepatitis B virus (HBV) affects 300 million people worldwide and is a major driver of liver diseases. But while decades of research have led to vaccines, antivirals, and a better understanding of the virus, how this pathogen establishes persistent infection in cells at the molecular level remains poorly understood.< . . .